Global Anti-Infective Vaccines Market Insights, Forecast to 2025

Publisher Name :
Date: 19-Jun-2019
No. of pages: 121
Inquire Before Buying

Anti-infective vaccines are the most effective public health measure taken to fight infectious diseases.

The global Anti-Infective Vaccines market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Anti-Infective Vaccines market based on company, product type, end user and key regions.

This report studies the global market size of Anti-Infective Vaccines in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Anti-Infective Vaccines in these regions.

This research report categorizes the global Anti-Infective Vaccines market by top players/brands, region, type and end user. This report also studies the global Anti-Infective Vaccines market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:

- Emergent BioDefense Operations Lansing Inc.

- Sanofi Pasteur

- Merck & Co.

- MedImmune LLC

- Novartis Vaccines

- Diagnostics Ltd.

- Intercell Biomedical

- MassBiologics

- Barr Labs, Inc.

- Organon Teknika Co.

- GlaxoSmithKline Biologicals

- CSL Ltd.

- ID Biomedical Co.

- Protein Sciences Co.

- Wyeth Pharmaceuticals, Inc.

- Berna Biotech

Market size by Product

- Inactivated vaccines

- Conjugate vaccines

- Live/attenuated vaccines

Market size by End User

- Bacterial diseases

- Viral diseases

Market size by Region

- North America

- - United States

- - Canada

- - Mexico

- Asia-Pacific

- - China

- - India

- - Japan

- - South Korea

- - Australia

- - Indonesia

- - Singapore

- - Malaysia

- - Philippines

- - Thailand

- - Vietnam

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Spain

- - Russia

- Central & South America

- - Brazil

- - Rest of Central & South America

- Middle East & Africa

- - GCC Countries

- - Turkey

- - Egypt

- - South Africa

The study objectives of this report are:

- To study and analyze the global Anti-Infective Vaccines market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.

- To understand the structure of Anti-Infective Vaccines market by identifying its various subsegments.

- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

- Focuses on the key global Anti-Infective Vaccines companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.

- To project the value and sales volume of Anti-Infective Vaccines submarkets, with respect to key regions.

- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Anti-Infective Vaccines are as follows:

- History Year: 2014-2018

- Base Year: 2018

- Estimated Year: 2019

- Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Anti-Infective Vaccines market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Global Anti-Infective Vaccines Market Insights, Forecast to 2025

Table of Contents
1 Study Coverage
1.1 Anti-Infective Vaccines Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Anti-Infective Vaccines Market Size Growth Rate by Product
1.4.2 Inactivated vaccines
1.4.3 Conjugate vaccines
1.4.4 Live/attenuated vaccines
1.5 Market by End User
1.5.1 Global Anti-Infective Vaccines Market Size Growth Rate by End User
1.5.2 Bacterial diseases
1.5.3 Viral diseases
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Anti-Infective Vaccines Market Size
2.1.1 Global Anti-Infective Vaccines Revenue 2014-2025
2.1.2 Global Anti-Infective Vaccines Sales 2014-2025
2.2 Anti-Infective Vaccines Growth Rate by Regions
2.2.1 Global Anti-Infective Vaccines Sales by Regions
2.2.2 Global Anti-Infective Vaccines Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Anti-Infective Vaccines Sales by Manufacturers
3.1.1 Anti-Infective Vaccines Sales by Manufacturers
3.1.2 Anti-Infective Vaccines Sales Market Share by Manufacturers
3.1.3 Global Anti-Infective Vaccines Market Concentration Ratio (CR5 and HHI)
3.2 Anti-Infective Vaccines Revenue by Manufacturers
3.2.1 Anti-Infective Vaccines Revenue by Manufacturers (2014-2019)
3.2.2 Anti-Infective Vaccines Revenue Share by Manufacturers (2014-2019)
3.3 Anti-Infective Vaccines Price by Manufacturers
3.4 Anti-Infective Vaccines Manufacturing Base Distribution, Product Types
3.4.1 Anti-Infective Vaccines Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Anti-Infective Vaccines Product Type
3.4.3 Date of International Manufacturers Enter into Anti-Infective Vaccines Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Anti-Infective Vaccines Sales by Product
4.2 Global Anti-Infective Vaccines Revenue by Product
4.3 Anti-Infective Vaccines Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Anti-Infective Vaccines Breakdown Data by End User
6 North America
6.1 North America Anti-Infective Vaccines by Countries
6.1.1 North America Anti-Infective Vaccines Sales by Countries
6.1.2 North America Anti-Infective Vaccines Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Anti-Infective Vaccines by Product
6.3 North America Anti-Infective Vaccines by End User
7 Europe
7.1 Europe Anti-Infective Vaccines by Countries
7.1.1 Europe Anti-Infective Vaccines Sales by Countries
7.1.2 Europe Anti-Infective Vaccines Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Anti-Infective Vaccines by Product
7.3 Europe Anti-Infective Vaccines by End User
8 Asia Pacific
8.1 Asia Pacific Anti-Infective Vaccines by Countries
8.1.1 Asia Pacific Anti-Infective Vaccines Sales by Countries
8.1.2 Asia Pacific Anti-Infective Vaccines Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Anti-Infective Vaccines by Product
8.3 Asia Pacific Anti-Infective Vaccines by End User
9 Central & South America
9.1 Central & South America Anti-Infective Vaccines by Countries
9.1.1 Central & South America Anti-Infective Vaccines Sales by Countries
9.1.2 Central & South America Anti-Infective Vaccines Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Anti-Infective Vaccines by Product
9.3 Central & South America Anti-Infective Vaccines by End User
10 Middle East and Africa
10.1 Middle East and Africa Anti-Infective Vaccines by Countries
10.1.1 Middle East and Africa Anti-Infective Vaccines Sales by Countries
10.1.2 Middle East and Africa Anti-Infective Vaccines Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Anti-Infective Vaccines by Product
10.3 Middle East and Africa Anti-Infective Vaccines by End User
11 Company Profiles
11.1 Emergent BioDefense Operations Lansing Inc.
11.1.1 Emergent BioDefense Operations Lansing Inc. Company Details
11.1.2 Company Business Overview
11.1.3 Emergent BioDefense Operations Lansing Inc. Anti-Infective Vaccines Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Emergent BioDefense Operations Lansing Inc. Anti-Infective Vaccines Products Offered
11.1.5 Emergent BioDefense Operations Lansing Inc. Recent Development
11.2 Sanofi Pasteur
11.2.1 Sanofi Pasteur Company Details
11.2.2 Company Business Overview
11.2.3 Sanofi Pasteur Anti-Infective Vaccines Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Sanofi Pasteur Anti-Infective Vaccines Products Offered
11.2.5 Sanofi Pasteur Recent Development
11.3 Merck & Co.
11.3.1 Merck & Co. Company Details
11.3.2 Company Business Overview
11.3.3 Merck & Co. Anti-Infective Vaccines Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Merck & Co. Anti-Infective Vaccines Products Offered
11.3.5 Merck & Co. Recent Development
11.4 MedImmune LLC
11.4.1 MedImmune LLC Company Details
11.4.2 Company Business Overview
11.4.3 MedImmune LLC Anti-Infective Vaccines Sales, Revenue and Gross Margin (2014-2019)
11.4.4 MedImmune LLC Anti-Infective Vaccines Products Offered
11.4.5 MedImmune LLC Recent Development
11.5 Novartis Vaccines
11.5.1 Novartis Vaccines Company Details
11.5.2 Company Business Overview
11.5.3 Novartis Vaccines Anti-Infective Vaccines Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Novartis Vaccines Anti-Infective Vaccines Products Offered
11.5.5 Novartis Vaccines Recent Development
11.6 Diagnostics Ltd.
11.6.1 Diagnostics Ltd. Company Details
11.6.2 Company Business Overview
11.6.3 Diagnostics Ltd. Anti-Infective Vaccines Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Diagnostics Ltd. Anti-Infective Vaccines Products Offered
11.6.5 Diagnostics Ltd. Recent Development
11.7 Intercell Biomedical
11.7.1 Intercell Biomedical Company Details
11.7.2 Company Business Overview
11.7.3 Intercell Biomedical Anti-Infective Vaccines Sales, Revenue and Gross Margin (2014-2019)
11.7.4 Intercell Biomedical Anti-Infective Vaccines Products Offered
11.7.5 Intercell Biomedical Recent Development
11.8 MassBiologics
11.8.1 MassBiologics Company Details
11.8.2 Company Business Overview
11.8.3 MassBiologics Anti-Infective Vaccines Sales, Revenue and Gross Margin (2014-2019)
11.8.4 MassBiologics Anti-Infective Vaccines Products Offered
11.8.5 MassBiologics Recent Development
11.9 Barr Labs, Inc.
11.9.1 Barr Labs, Inc. Company Details
11.9.2 Company Business Overview
11.9.3 Barr Labs, Inc. Anti-Infective Vaccines Sales, Revenue and Gross Margin (2014-2019)
11.9.4 Barr Labs, Inc. Anti-Infective Vaccines Products Offered
11.9.5 Barr Labs, Inc. Recent Development
11.10 Organon Teknika Co.
11.10.1 Organon Teknika Co. Company Details
11.10.2 Company Business Overview
11.10.3 Organon Teknika Co. Anti-Infective Vaccines Sales, Revenue and Gross Margin (2014-2019)
11.10.4 Organon Teknika Co. Anti-Infective Vaccines Products Offered
11.10.5 Organon Teknika Co. Recent Development
11.11 GlaxoSmithKline Biologicals
11.12 CSL Ltd.
11.13 ID Biomedical Co.
11.14 Protein Sciences Co.
11.15 Wyeth Pharmaceuticals, Inc.
11.16 Berna Biotech
12 Future Forecast
12.1 Anti-Infective Vaccines Market Forecast by Regions
12.1.1 Global Anti-Infective Vaccines Sales Forecast by Regions 2019-2025
12.1.2 Global Anti-Infective Vaccines Revenue Forecast by Regions 2019-2025
12.2 Anti-Infective Vaccines Market Forecast by Product
12.2.1 Global Anti-Infective Vaccines Sales Forecast by Product 2019-2025
12.2.2 Global Anti-Infective Vaccines Revenue Forecast by Product 2019-2025
12.3 Anti-Infective Vaccines Market Forecast by End User
12.4 North America Anti-Infective Vaccines Forecast
12.5 Europe Anti-Infective Vaccines Forecast
12.6 Asia Pacific Anti-Infective Vaccines Forecast
12.7 Central & South America Anti-Infective Vaccines Forecast
12.8 Middle East and Africa Anti-Infective Vaccines Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Anti-Infective Vaccines Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables and Figures
Figure Anti-Infective Vaccines Product Picture
Table Anti-Infective Vaccines Market Segments
Table Key Manufacturers Anti-Infective Vaccines Covered
Table Global Anti-Infective Vaccines Market Size Growth Rate by Product 2019-2025 (K Units) & (Million US$)
Figure Global Anti-Infective Vaccines Sales Market Share by Product 2014-2025
Figure Inactivated vaccines Product Picture
Table Major Manufacturers of Inactivated vaccines
Figure Conjugate vaccines Product Picture
Table Major Manufacturers of Conjugate vaccines
Figure Live/attenuated vaccines Product Picture
Table Major Manufacturers of Live/attenuated vaccines
Table Global Anti-Infective Vaccines Market Size Growth Rate by End User 2019-2025 (K Units)
Figure Bacterial diseases
Figure Viral diseases
Figure Anti-Infective Vaccines Report Years Considered
Figure Global Anti-Infective Vaccines Market Size 2014-2025 (Million US$)
Figure Global Anti-Infective Vaccines Sales 2014-2025 (K Units)
Table Global Anti-Infective Vaccines Market Size by Regions 2014-2019 (K Units) & (Million US$)
Table Global Anti-Infective Vaccines Sales by Regions 2014-2019 (K Units)
Table Global Anti-Infective Vaccines Sales Market Share by Regions 2014-2019
Figure Global Anti-Infective Vaccines Sales Market Share by Regions 2014-2019
Figure 2018 Global Anti-Infective Vaccines Sales Market Share by Regions
Table Global Anti-Infective Vaccines Revenue by Regions 2014-2019 (Million US$)
Table Global Anti-Infective Vaccines Revenue Market Share by Regions 2014-2019
Figure Global Anti-Infective Vaccines Revenue Market Share by Regions 2014-2019
Figure 2018 Global Anti-Infective Vaccines Revenue Market Share by Regions
Table Global Anti-Infective Vaccines Sales by Manufacturers (2014-2019) (K Units)
Table Global Anti-Infective Vaccines Sales Share by Manufacturers (2014-2019)
Figure Global Anti-Infective Vaccines Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Anti-Infective Vaccines Revenue by Manufacturers (2014-2019) (Million USD)
Table Anti-Infective Vaccines Revenue Share by Manufacturers (2014-2019)
Figure Anti-Infective Vaccines Value Share by Manufacturers in 2018
Table Key Manufacturers Anti-Infective Vaccines Price (2014-2019) (USD/Unit)
Table Anti-Infective Vaccines Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Anti-Infective Vaccines Product Type
Table Date of International Manufacturers Enter into Anti-Infective Vaccines Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Anti-Infective Vaccines Sales by Product (2014-2019) (K Units)
Table Global Anti-Infective Vaccines Sales Share by Product (2014-2019)
Figure Global Anti-Infective Vaccines Sales Market Share by Product (2014-2019)
Figure Global Anti-Infective Vaccines Sales Market Share by Product in 2018
Table Global Anti-Infective Vaccines Revenue by Product (2014-2019) (Million US$)
Table Global Anti-Infective Vaccines Revenue Share by Product (2014-2019)
Figure Global Anti-Infective Vaccines Revenue Market Share by Product (2014-2019)
Figure Global Anti-Infective Vaccines Revenue Market Share by Product in 2018
Table Anti-Infective Vaccines Price by Product 2014-2019 (USD/Unit)
Table Global Anti-Infective Vaccines Sales by End User (2014-2019) (K Units)
Table Global Anti-Infective Vaccines Sales Share by End User (2014-2019)
Figure Global Sales Anti-Infective Vaccines Market Share by End User (2014-2019)
Figure Global Sales Anti-Infective Vaccines Market Share by End User in 2018
Figure North America Anti-Infective Vaccines Sales Growth Rate 2014-2019 (K Units)
Figure North America Anti-Infective Vaccines Revenue Growth Rate 2014-2019 (Million US$)
Table North America Anti-Infective Vaccines Sales by Countries (2014-2019) (K Units)
Table North America Anti-Infective Vaccines Sales Market Share by Countries (2014-2019)
Figure 2018 North America Anti-Infective Vaccines Sales Market Share by Countries
Table North America Anti-Infective Vaccines Revenue by Countries (2014-2019) (Million US$)
Table North America Anti-Infective Vaccines Revenue Market Share by Countries (2014-2019)
Figure 2018 North America Anti-Infective Vaccines Revenue Market Share by Countries
Figure United States Anti-Infective Vaccines Sales Growth Rate (2014-2019) (K Units)
Figure United States Anti-Infective Vaccines Revenue Growth Rate (2014-2019) (K Units)
Figure Canada Anti-Infective Vaccines Sales Growth Rate (2014-2019) (K Units)
Figure Canada Anti-Infective Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico Anti-Infective Vaccines Sales Growth Rate (2014-2019) (K Units)
Figure Mexico Anti-Infective Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Table North America Anti-Infective Vaccines Sales by Product (2014-2019) (K Units)
Table North America Anti-Infective Vaccines Sales Market Share by Product (2014-2019)
Figure 2018 North America Anti-Infective Vaccines Market Share by Product
Table North America Anti-Infective Vaccines Sales by End User (2014-2019) (K Units)
Table North America Anti-Infective Vaccines Sales Market Share by End User (2014-2019)
Figure 2018 North America Anti-Infective Vaccines Market Share by End User
Figure Europe Anti-Infective Vaccines Sales Growth Rate 2014-2019 (K Units)
Figure Europe Anti-Infective Vaccines Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Anti-Infective Vaccines Sales by Countries (2014-2019) (K Units)
Table Europe Anti-Infective Vaccines Sales Market Share by Countries (2014-2019)
Figure 2018 Europe Anti-Infective Vaccines Sales Market Share by Countries
Table Europe Anti-Infective Vaccines Revenue by Countries (2014-2019) (Million US$)
Table Europe Anti-Infective Vaccines Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe Anti-Infective Vaccines Revenue Market Share by Countries
Figure Germany Anti-Infective Vaccines Sales Growth Rate (2014-2019) (K Units)
Figure Germany Anti-Infective Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure France Anti-Infective Vaccines Sales Growth Rate (2014-2019) (K Units)
Figure France Anti-Infective Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure UK Anti-Infective Vaccines Sales Growth Rate (2014-2019) (K Units)
Figure UK Anti-Infective Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy Anti-Infective Vaccines Sales Growth Rate (2014-2019) (K Units)
Figure Italy Anti-Infective Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia Anti-Infective Vaccines Sales Growth Rate (2014-2019) (K Units)
Figure Russia Anti-Infective Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Table Europe Anti-Infective Vaccines Sales by Product (2014-2019) (K Units)
Table Europe Anti-Infective Vaccines Sales Market Share by Product (2014-2019)
Figure 2018 Europe Anti-Infective Vaccines Market Share by Product
Table Europe Anti-Infective Vaccines Sales by End User (2014-2019) (K Units)
Table Europe Anti-Infective Vaccines Sales Market Share by End User (2014-2019)
Figure 2018 Europe Anti-Infective Vaccines Market Share by End User
Figure Asia Pacific Anti-Infective Vaccines Sales Growth Rate 2014-2019 (K Units)
Figure Asia Pacific Anti-Infective Vaccines Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Anti-Infective Vaccines Sales by Countries (2014-2019) (K Units)
Table Asia Pacific Anti-Infective Vaccines Sales Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Anti-Infective Vaccines Sales Market Share by Countries
Table Asia Pacific Anti-Infective Vaccines Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific Anti-Infective Vaccines Revenue Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Anti-Infective Vaccines Revenue Market Share by Countries
Figure China Anti-Infective Vaccines Sales Growth Rate (2014-2019) (K Units)
Figure China Anti-Infective Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Anti-Infective Vaccines Sales Growth Rate (2014-2019) (K Units)
Figure Japan Anti-Infective Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Anti-Infective Vaccines Sales Growth Rate (2014-2019) (K Units)
Figure Korea Anti-Infective Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure India Anti-Infective Vaccines Sales Growth Rate (2014-2019) (K Units)
Figure India Anti-Infective Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Anti-Infective Vaccines Sales Growth Rate (2014-2019) (K Units)
Figure Australia Anti-Infective Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Anti-Infective Vaccines Sales Growth Rate (2014-2019) (K Units)
Figure Indonesia Anti-Infective Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Anti-Infective Vaccines Sales Growth Rate (2014-2019) (K Units)
Figure Malaysia Anti-Infective Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Anti-Infective Vaccines Sales Growth Rate (2014-2019) (K Units)
Figure Philippines Anti-Infective Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Anti-Infective Vaccines Sales Growth Rate (2014-2019) (K Units)
Figure Thailand Anti-Infective Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Anti-Infective Vaccines Sales Growth Rate (2014-2019) (K Units)
Figure Vietnam Anti-Infective Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore Anti-Infective Vaccines Sales Growth Rate (2014-2019) (K Units)
Figure Singapore Anti-Infective Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific Anti-Infective Vaccines Sales by Product (2014-2019) (K Units)
Table Asia Pacific Anti-Infective Vaccines Sales Market Share by Product (2014-2019)
Figure 2018 Asia Pacific Anti-Infective Vaccines Market Share by Product
Table Asia Pacific Anti-Infective Vaccines Sales by End User (2014-2019) (K Units)
Table Asia Pacific Anti-Infective Vaccines Sales Market Share by End User (2014-2019)
Figure 2018 Asia Pacific Anti-Infective Vaccines Market Share by End User
Figure Central & South America Anti-Infective Vaccines Sales Growth Rate 2014-2019 (K Units)
Figure Central & South America Anti-Infective Vaccines Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Anti-Infective Vaccines Sales by Countries (2014-2019) (K Units)
Table Central & South America Anti-Infective Vaccines Sales Market Share by Countries (2014-2019)
Figure 2018 Central & South America Anti-Infective Vaccines Sales Market Share by Countries
Table Central & South America Anti-Infective Vaccines Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Anti-Infective Vaccines Revenue Market Share by Countries (2014-2019)
Figure 2018 Central & South America Anti-Infective Vaccines Revenue Market Share by Countries
Figure Brazil Anti-Infective Vaccines Sales Growth Rate (2014-2019) (K Units)
Figure Brazil Anti-Infective Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina Anti-Infective Vaccines Sales Growth Rate (2014-2019) (K Units)
Figure Argentina Anti-Infective Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America Anti-Infective Vaccines Sales by Product (2014-2019) (K Units)
Table Central & South America Anti-Infective Vaccines Sales Market Share by Product (2014-2019)
Figure 2018 Central & South America Anti-Infective Vaccines Market Share by Product
Table Central & South America Anti-Infective Vaccines Sales by End User (2014-2019) (K Units)
Table Central & South America Anti-Infective Vaccines Sales Market Share by End User (2014-2019)
Figure 2018 Central & South America Anti-Infective Vaccines Market Share by End User
Figure Middle East and Africa Anti-Infective Vaccines Sales Growth Rate 2014-2019 (K Units)
Figure Middle East and Africa Anti-Infective Vaccines Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Anti-Infective Vaccines Sales by Countries (2014-2019) (K Units)
Table Middle East and Africa Anti-Infective Vaccines Sales Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Anti-Infective Vaccines Sales Market Share by Countries
Table Middle East and Africa Anti-Infective Vaccines Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Anti-Infective Vaccines Revenue Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Anti-Infective Vaccines Revenue Market Share by Countries
Figure GCC Countries Anti-Infective Vaccines Sales Growth Rate (2014-2019) (K Units)
Figure GCC Countries Anti-Infective Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey Anti-Infective Vaccines Sales Growth Rate (2014-2019) (K Units)
Figure Turkey Anti-Infective Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt Anti-Infective Vaccines Sales Growth Rate (2014-2019) (K Units)
Figure Egypt Anti-Infective Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa Anti-Infective Vaccines Sales Growth Rate (2014-2019) (K Units)
Figure South Africa Anti-Infective Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa Anti-Infective Vaccines Sales by Product (2014-2019) (K Units)
Table Middle East and Africa Anti-Infective Vaccines Sales Market Share by Product (2014-2019)
Figure 2018 Middle East and Africa Anti-Infective Vaccines Market Share by Product
Table Middle East and Africa Anti-Infective Vaccines Sales by End User (2014-2019) (K Units)
Table Middle East and Africa Anti-Infective Vaccines Sales Market Share by End User (2014-2019)
Figure 2018 Middle East and Africa Anti-Infective Vaccines Market Share by End User
Table Emergent BioDefense Operations Lansing Inc. Company Details
Table Emergent BioDefense Operations Lansing Inc. Anti-Infective Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Emergent BioDefense Operations Lansing Inc. Recent Development
Table Sanofi Pasteur Company Details
Table Sanofi Pasteur Anti-Infective Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Sanofi Pasteur Recent Development
Table Merck & Co. Company Details
Table Merck & Co. Anti-Infective Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Merck & Co. Recent Development
Table MedImmune LLC Company Details
Table MedImmune LLC Anti-Infective Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table MedImmune LLC Recent Development
Table Novartis Vaccines Company Details
Table Novartis Vaccines Anti-Infective Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Novartis Vaccines Recent Development
Table Diagnostics Ltd. Company Details
Table Diagnostics Ltd. Anti-Infective Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Diagnostics Ltd. Recent Development
Table Intercell Biomedical Company Details
Table Intercell Biomedical Anti-Infective Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Intercell Biomedical Recent Development
Table MassBiologics Company Details
Table MassBiologics Anti-Infective Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table MassBiologics Recent Development
Table Barr Labs, Inc. Company Details
Table Barr Labs, Inc. Anti-Infective Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Barr Labs, Inc. Recent Development
Table Organon Teknika Co. Company Details
Table Organon Teknika Co. Anti-Infective Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Organon Teknika Co. Recent Development
Table GlaxoSmithKline Biologicals Company Details
Table CSL Ltd. Company Details
Table ID Biomedical Co. Company Details
Table Protein Sciences Co. Company Details
Table Wyeth Pharmaceuticals, Inc. Company Details
Table Berna Biotech Company Details
Table Global Anti-Infective Vaccines Sales Forecast by Regions 2019-2025 (K Units)
Table Global Anti-Infective Vaccines Sales Market Share Forecast by Regions 2019-2025
Table Global Anti-Infective Vaccines Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global Anti-Infective Vaccines Revenue Market Share Forecast by Regions 2019-2025
Table Global Anti-Infective Vaccines Sales Forecast by Product 2019-2025 (K Units)
Table Global Anti-Infective Vaccines Sales Market Share Forecast by Product 2019-2025
Table Global Anti-Infective Vaccines Revenue Forecast by Product 2019-2025 (Million US$)
Table Global Anti-Infective Vaccines Revenue Market Share Forecast by Product 2019-2025
Table Global Anti-Infective Vaccines Sales Forecast by End User 2019-2025 (K Units)
Table Global Anti-Infective Vaccines Sales Market Share Forecast by End User 2019-2025
Figure North America Anti-Infective Vaccines Sales Growth Rate Forecast (2019-2025) (K Units)
Figure North America Anti-Infective Vaccines Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe Anti-Infective Vaccines Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Europe Anti-Infective Vaccines Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific Anti-Infective Vaccines Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Asia Pacific Anti-Infective Vaccines Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America Anti-Infective Vaccines Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Central & South America Anti-Infective Vaccines Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa Anti-Infective Vaccines Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Middle East and Africa Anti-Infective Vaccines Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table Anti-Infective Vaccines Value Chain
Table Anti-Infective Vaccines Customers List
Table Anti-Infective Vaccines Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs